Schmidt Leigh S, Ghosoph Jennifer M, Margosan Dennis A, Smilanick Joseph L
USDA-ARS, San Joaquin Valley Agricultural Sciences Center, 9611 South Riverbend Avenue, Parlier CA 93648.
Plant Dis. 2006 Jun;90(6):765-770. doi: 10.1094/PD-90-0765.
Thiabendazole (TBZ) is commonly applied to harvested citrus fruit in packinghouses to control citrus green mold, caused by Penicillium digitatum. Although TBZ is not used before harvest, another benzimidazole, thiophanate methyl, is commonly used in Florida and may be introduced soon in California to control postharvest decay of citrus fruit. Isolates from infected lemons and oranges were collected from many geographically diverse locations in California. Thirty-five isolates collected from commercial groves and residential trees were sensitive to TBZ, while 19 of 74 isolates collected from 10 packinghouses were resistant to TBZ. Random amplified polymorphic DNA analysis indicated that the isolates were genetically distinct and differed from each other. Nineteen TBZ-resistant isolates and a known TBZ-resistant isolate displayed a point mutation in the β-tubulin gene sequence corresponding to amino acid codon position 200. Thymine was replaced by adenine (TTC → TAC), which changed the phenylalanine (F) to tyrosine (Y). In contrast, for 49 TBZ-sensitive isolates that were sequenced, no mutations at this or any other codon positions were found. All of the isolates of P. digitatum resistant to TBZ collected from a geographically diverse sample of California packinghouses appeared to have the same point mutation conferring thiabendazole resistance.
噻苯达唑(TBZ)通常在包装厂用于处理收获后的柑橘类水果,以控制由指状青霉引起的柑橘绿霉病。虽然TBZ在收获前不使用,但另一种苯并咪唑类药剂甲基硫菌灵,在佛罗里达州普遍使用,并且可能很快在加利福尼亚州引入,用于控制柑橘类水果的采后腐烂。从加利福尼亚州许多地理位置不同的地方收集了感染柠檬和橙子的分离株。从商业果园和住宅树木中收集的35个分离株对TBZ敏感,而从10个包装厂收集的74个分离株中有19个对TBZ耐药。随机扩增多态性DNA分析表明,这些分离株在遗传上是不同的,彼此存在差异。19个TBZ耐药分离株和一个已知的TBZ耐药分离株在β-微管蛋白基因序列中对应于氨基酸密码子位置200处显示出一个点突变。胸腺嘧啶被腺嘌呤取代(TTC→TAC),这将苯丙氨酸(F)变为酪氨酸(Y)。相比之下,对49个进行测序的TBZ敏感分离株而言,在该密码子位置或任何其他密码子位置均未发现突变。从加利福尼亚州包装厂的不同地理位置样本中收集的所有对TBZ耐药的指状青霉分离株似乎都具有相同的赋予噻苯达唑抗性的点突变。